{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T14:18:15Z","timestamp":1770473895522,"version":"3.49.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1136\/ard.61.4.358","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:29:57Z","timestamp":1027765797000},"page":"358-361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Anticardiolipin antibodies in rheumatoid patients treated with etanercept or conventional combination therapy: direct and indirect evidence for a possible association with infections"],"prefix":"10.1016","volume":"61","author":[{"given":"G","family":"Ferraccioli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Mecchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Di Poi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Fabris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.61.4.358_bib1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1056\/NEJM199901283400401","article-title":"A trial of etanercept a recombinant tumor necrosis factor receptor: Fc fusion protein in patients with rheumatoid arthritis receiving methotrexate","volume":"340","author":"Weinblatt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.61.4.358_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJM199707173370301","article-title":"Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein","volume":"337","author":"Moreland","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.61.4.358_bib3","doi-asserted-by":"crossref","first-page":"478","DOI":"10.7326\/0003-4819-130-6-199903160-00004","article-title":"Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial","volume":"130","author":"Moreland","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.61.4.358_bib4","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0002-9343(96)00060-5","article-title":"Natural history and risk factors for thrombosis in 360 patients with anti-phospholipid antibodies: a four year prospective study from the Italian Registry","volume":"100","author":"Finazzi","year":"1996","journal-title":"Am J Med"},{"key":"10.1136\/ard.61.4.358_bib5","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.4049\/jimmunol.161.11.5937","article-title":"TNF\/lymphotoxin\u03b1 double-mutant mice resist septic arthritis but display increased mortality in response to Staphylococcus aureus","volume":"161","author":"Hultgren","year":"1998","journal-title":"J Immunol"},{"key":"10.1136\/ard.61.4.358_bib6","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.4049\/jimmunol.160.12.6072","article-title":"Blockade of endogenous TNF\u03b1 exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms","volume":"160","author":"Allendoerfer","year":"1998","journal-title":"J Immunol"},{"key":"10.1136\/ard.61.4.358_bib7","first-page":"567","article-title":"Carriage of Staphylococcus aureus in random samples of a normal population","volume":"65","author":"Noble","year":"1967","journal-title":"J Hyg Camb"},{"key":"10.1136\/ard.61.4.358_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1128\/br.27.1.56-71.1963","article-title":"Healthy carriage of Staphylococcus aureus: its prevalence and importance","volume":"27","author":"Williams","year":"1963","journal-title":"Bacteriol Rev"},{"key":"10.1136\/ard.61.4.358_bib9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7326\/0003-4819-120-1-199401010-00003","article-title":"Association of chronic nasal carriage of Staf. A and higher relapse rate in Wegener granulomatosis","volume":"120","author":"Stegeman","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.61.4.358_bib10","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/374546a0","article-title":"CpG motifs in bacterial DNA trigger direct B cell activation","volume":"374","author":"Krieg","year":"1995","journal-title":"Nature"},{"key":"10.1136\/ard.61.4.358_bib11","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1172\/JCI118894","article-title":"Activation of human B cells by phosphorothioate oligodeoxynucleotides","volume":"98","author":"Liang","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.61.4.358_bib12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1046\/j.1365-2567.1999.00811.x","article-title":"DNA activates human immune cells through a CpG sequence-dependent manner","volume":"97","author":"Bauer","year":"1999","journal-title":"Immunology"},{"key":"10.1136\/ard.61.4.358_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0952-7915(99)00048-5","article-title":"The role of CpG motifs in innate immunity","volume":"12","author":"Krieg","year":"2000","journal-title":"Curr Opin Immunol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724094093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724094093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.61.4.358","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T05:27:07Z","timestamp":1737437227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724094093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["S0003496724094093"],"URL":"https:\/\/doi.org\/10.1136\/ard.61.4.358","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2002,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticardiolipin antibodies in rheumatoid patients treated with etanercept or conventional combination therapy: direct and indirect evidence for a possible association with infections","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.61.4.358","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 Copyright 2002 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}